Medtronic plc, a global leader in healthcare technology, received US Food and Drug Administration (FDA) approval for the OmniaSecure defibrillation lead for placement within the right ventricle. The lead, built
Medtronic is an Ireland-based medical device company that manufactures and supplies therapeutic and diagnostic equipment to treat chronic diseases across the globe.